SPC461

Quizartíníb

  • Status:
    Veitt
  • Application date:
    27.3.2024
  • Application published:
    15.4.2024
  • Grant published:
    15.10.2025
  • Max expiry date:
    13.5.2035
  • Medicine name:
    Vanflyta
  • Medicine for children:
    No

Timeline

Today
27.3.2024Application
15.4.2024Publication
15.10.2025Registration
13.5.2035Expires

Marketing license

  • IS authorization number:
    EU/1/23/1768
  • Date:
    28.11.2023
  • Foreign authorization number:
    EU/1/23/1768
  • Date:
    6.11.2023

Owner

  • Name:
    Ambit Biosciences Corporation
  • Address:
    211 Mount Airy Road, Basking Ridge, 07920 New Jersey US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 08.10.2025

Upload documents